About the Authors

Andrew Gantt

Andrew Gantt

Andrew Gantt focuses on health care and life sciences regulatory counseling, complex transactions, and strategic business advice. Mr. Gantt represents a wide variety of health care and life sciences companies, health plans, health care providers, manufacturers, suppliers, health care IT, information services, and eHealth companies in corporate and regulatory matters. In addition, he advises venture capital groups, private equity funds, investment banks and other investors and financial groups on health care regulatory issues in connection with the financing of health care mergers and acquisitions, securities offerings and financings.  More

Wendy Goldstein

Wendy Goldstein

Wendy Goldstein concentrates in healthcare fraud and abuse and government health care program matters relevant to manufacturers, payors and other ancillary providers in the health care life sciences space.  She counsels clients regarding the research, manufacture, sale, promotion, distribution, pricing and import/export of pharmaceuticals, biologics and medical devices; government health care program compliance risks; drafting and negotiating co-promote agreements, drug rebate agreements, supply chain arrangements, fee-for-service agreements and third-party vendor arrangements; conducting health regulatory due diligences; defending pharmaceutical manufacturers in all phases of government investigations and inquiries; and counseling third-party payors in connection with the delivery of outpatient prescription drug benefit and specialty drug benefit programs offered under insured (commercial and government) and self-insured products. More

Natasha Leskovsek

Natasha Leskovsek

Natasha Leskovsek advises pharmaceutical, biotechnology, medical device and food/dietary supplement industry clients on FDA regulatory and clinical development matters. She also conducts regulatory diligence on behalf of entities investing in FDA-regulated companies. More

Philip Mitchell

Philip Mitchell

Philip Mitchell provides health regulatory counsel to a range of industry clients, including hospital systems, provider practice groups, management services organizations, clinical laboratories, managed care organizations and health insurers, pharmaceutical and biologic manufacturers, and specialty pharmacies, other proprietary and nonprofit health care enterprises, and investment firms. More

Sarah diFrancesca

Sarah diFrancesca

Sarah diFrancesca’s practice focuses on fraud and abuse, compliance, and regulatory issues within the pharmaceutical, medical device, and biotechnology industries. Her experience includes representing health care entities in connection with federal and state government investigations, inquires, settlements, and voluntary disclosures. More

Leave a Reply

Please log in using one of these methods to post your comment:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s